norfloxacin and amoxicillin-potassium clavulanate combination

norfloxacin has been researched along with amoxicillin-potassium clavulanate combination in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (14.29)	18.7374
1990's	2 (28.57)	18.2507
2000's	3 (42.86)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Claeys, G; Van den Abeele, AM; Verschraegen, G	1
Bruining, HA; Ong, GL; Postema, RR	1
Andreu, M; Coll, S; Gana, J; Guarner, C; Miñana, J; Mirelis, B; Novella, MT; Ortiz, J; Prats, G; Sábat, M; Solá, R; Soriano, G; Vila, MC	1
Aguilar, L; Alou, L; Cafini, F; Giménez, MJ; Prieto, J; Relaño, MT; Sevillano, D; Valero, E	1
Bedenic, B; Bubonja, M; Budimir, A; Topic, M	1
Farkas, A; Papp, M; Tornai, I; Udvardy, M	1
Kurz, X; McGettigan, P; Morales, D; Pacurariu, A; Pinheiro, L; Slattery, J	1

Reviews

1 review(s) available for norfloxacin and amoxicillin-potassium clavulanate combination

Article	Year
[Bacterial infections in liver cirrhosis]. Orvosi hetilap, 2007, Mar-04, Volume: 148, Issue:9 Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ascites; Bacteremia; Bacterial Infections; Cefotaxime; Cephalosporins; Ciprofloxacin; Fluoroquinolones; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Liver Cirrhosis; Norfloxacin; Peritonitis; Pneumonia, Bacterial; Primary Prevention; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2007

Article

Year

[Bacterial infections in liver cirrhosis].

Orvosi hetilap, 2007, Mar-04, Volume: 148, Issue:9

Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ascites; Bacteremia; Bacterial Infections; Cefotaxime; Cephalosporins; Ciprofloxacin; Fluoroquinolones; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Liver Cirrhosis; Norfloxacin; Peritonitis; Pneumonia, Bacterial; Primary Prevention; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections

2007

Other Studies

6 other study(ies) available for norfloxacin and amoxicillin-potassium clavulanate combination

Article	Year
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:1 Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin	1988
[Fever in intensive care: keep medications in mind at all times]. Nederlands tijdschrift voor geneeskunde, 1998, Oct-03, Volume: 142, Issue:40 Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Drug Hypersensitivity; Drug Therapy, Combination; Esophageal Diseases; Fever of Unknown Origin; Humans; Intensive Care Units; Male; Norfloxacin; Postoperative Complications; Suction; Treatment Outcome	1998
Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients. Hepatology (Baltimore, Md.), 1999, Volume: 29, Issue:4 Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Norfloxacin; Ofloxacin; Time Factors; Treatment Outcome	1999
Urine bactericidal activity against resistant Escherichia coli in an in vitro pharmacodynamic model simulating urine concentrations obtained after 2000/125 mg sustained-release co-amoxiclav and 400 mg norfloxacin administration. The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:4 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cystitis; Delayed-Action Preparations; Escherichia coli; Humans; Microbial Sensitivity Tests; Models, Biological; Norfloxacin; Urine	2006
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model. Chemotherapy, 2006, Volume: 52, Issue:6 Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Biomarkers; Cefadroxil; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Norfloxacin; Oxazolidinones; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2006
Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy. JAMA neurology, 2019, 07-01, Volume: 76, Issue:7 Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Case-Control Studies; Ciprofloxacin; Female; Fluoroquinolones; Humans; Incidence; Levofloxacin; Male; Middle Aged; Moxifloxacin; Norfloxacin; Ofloxacin; Peripheral Nervous System Diseases; Risk Factors; Sex Factors; United Kingdom	2019